Quantinuum has officially priced its initial public offering at $60 per share, moving past its initial target range of $45 to $50. The offering raised $1.68 billion, granting the quantum computing company a valuation of $15.6 billion as it joins the Nasdaq.
The move comes as the global technology sector faces pressure from shifting federal priorities, including new initiatives under the US CHIPS and Science Act. Quantinuum, which formed in 2021 through the merger of Honeywell Quantum Solutions and Cambridge Quantum, is now positioned as a high-value player in the race to scale trapped-ion processing technology.
Commercial Scaling and Market Position
Quantinuum currently maintains four commercial quantum systems, with plans to deploy a fifth system before the end of 2026. This IPO arrives during a period of intense competition in the industry, with firms like IBM recently committing to long-term R&D investments, according to a detailed report by Silicon Republic.
The capital raised will support the company’s roadmap for hardware development and software integration. The business currently works closely with partners like RIKEN to apply quantum processing to complex simulations. More details on the firm’s strategic focus, including its relationship with Honeywell, can be found in this analysis from Constellation Research.
Strategic Industry Benchmarking
Industry analysts view this listing as the largest quantum-computing public offering to date. The pricing action, confirmed in a report by TNW, provides a concrete valuation for a sector that has historically relied heavily on private equity and venture capital.
Quantinuum’s momentum is also linked to recent federal support. The company was recently allocated a share of $2 billion in funding under the CHIPS and Science Act to advance the fabrication of specialized optical components required for their hardware.